Brainstorm cell therapeutics to host kol webinar on current developments in the treatment of amyotrophic lateral sclerosis (als) on december 11, 2024

New york , dec. 2, 2024 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will host a key opinion leader (kol) webinar on wednesday, december 11, 2024 at 10:00 am et. to register, click here.
BCLI Ratings Summary
BCLI Quant Ranking